Future clinical uses of neurophysiological biomarkers to predict and monitor treatment response for schizophrenia

E-ISSN： 1749-6632|1344|1|105-119

ISSN： 0077-8923

Source： ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, Vol.1344, Iss.1, 2015-05, pp. : 105-119

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neurophysiological models for new treatment development in schizophrenia: early sensory approaches

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, Vol. 1344, Iss. 1, 2015-05 ,pp. : 92-104

John Wiley & Sons Inc

Access to resources Recommend Favorite

Blood Biomarkers Predict the Cognitive Effects of Aripiprazole in Patients with Acute Schizophrenia

By Hori Hikaru Yoshimura Reiji Katsuki Asuka Atake Kiyokazu Igata Ryohei Konishi Yuki Beppu Hiroki Tominaga Hirotaka

International Journal of Molecular Sciences, Vol. 18, Iss. 3, 2017-03 ,pp. : 568-568

MDPI

Access to resources Recommend Favorite

A Neurophysiological Perspective on a Preventive Treatment against Schizophrenia Using Transcranial Electric Stimulation of the Corticothalamic Pathway

By Pinault Didier

Brain Sciences, Vol. 7, Iss. 4, 2017-03 ,pp. : 34-34

MDPI

Access to resources Recommend Favorite

Clinical Uses of Botulinum Neurotoxins: Current Indications, Limitations and Future Developments

By Chen Sheng

Toxins, Vol. 4, Iss. 10, 2012-10 ,pp. : 913-939

MDPI

Access to resources Recommend Favorite

Theranostic Biomarkers for Schizophrenia

By Nikolac Perkovic Matea Nedic Erjavec Gordana Svob Strac Dubravka Uzun Suzana Kozumplik Oliver Pivac Nela

International Journal of Molecular Sciences, Vol. 18, Iss. 4, 2017-03 ,pp. : 733-733

MDPI

Access to resources Recommend Favorite